Posts by Muana Minkoué
biped.ai wins the Startup Champions Seed Night 2024
Life sciences shone during the 13th edition of the Startup Champions Seed Night gathering more than 500 people at the Forum Rolex and online! On 25 April 2024, 20 startups pitched their innovative plans to make an impact in the world of modern technology. Co-organised by EPFL (EPFL Alumni and Startup Launchpad) &…
Read MoreBioFIT
BioFIT is taking place on 2-3 December 2025 in Strasbourg, France. With the highest attending rate of TTOs, research institutes and academia together with big pharma, emerging and small biotech, diagnostic companies, pre-seed / seed / Series A investors, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations, early-stage innovation deals and pre-seed, seed and…
Read MoreAzur Cell Therapies and Antion Biosciences get funding from FONGIT Innovation Fund (FIF)
The FONGIT Innovation Fund (FIF) continues to bolster the growth of new technologies in Geneva, with its latest grants awarded to Azure Cell Therapies and Antion Biosciences for their innovative projects that are poised to impact not only Geneva’s economic growth but also global advancements. The FONGIT Innovation Fund (FIF) fosters innovation and…
Read MoreRobert Mardini will be the new Director General of the University Hospital of Geneva (HUG)
The Geneva cantonal government has confirmed the appointment of Robert Mardini as Director General of the University Hospital of Geneva (HUG) as of 21 September 2024. This confirmation follows his appointment by the HUG Board of directors on 25 March 2024. 24th April 2024, Geneva – “We are very pleased to welcome Robert…
Read MoreIsospec Analytics get support from FIT
IsoSpec Analytics, specialising in advanced biomolecular analysis, receives a Tech Seed loan of CHF 100’000 from the Foundation for Technological Innovation (FIT). This EPFL spin-off develops disruptive analytical technologies to generate next-level molecular intelligence, accelerating the development of nutritional supplements, crop protection products and pharmaceuticals. This technology also enables biomarker discovery for early…
Read MoreThe HES-SO strengthens life sciences education and research in the Canton of Valais
The HES-SO Valais-Wallis School of Engineering is expanding its training and research offering in the life sciences, marking an important step in its alignment with the rapid developments in the biopharmaceutical and food industries in Switzerland. Responding to industry transformations and technological advancements, the Bachelor of Science HES-SO program in Life Sciences Technologies…
Read MoreASPIVIX announces a growth partnership with Bayer (Schweiz) AG
ASPIVIX announces its partnership with Bayer (Schweiz) AG in Switzerland, aimed at transforming gynaecological procedures. Together, they are introducing Carevix™, a CE-Marked cervical stabiliser designed to minimise pain and bleeding during transcervical procedures, including IUD placement. This Swiss collaboration combines Bayer (Schweiz) AG’s expertise in contraceptive solutions with ASPIVIX’s commitment to modernising gynaecology.…
Read MoreAdrian Hunn appointed Swiss Medtech Managing Director
The Swiss Medtech Board of Directors has selected Adrian Hunn to be new Managing Director. The 45-year-old will assume his position in Bern on 1 June 2024. Adrian Hunn is a proven leader, possesses in-depth knowledge of the medical technology industry, has represented the sector on national and international stages, and brings extensive…
Read MoreAddex and Perceptive launch Neurosterix with USD 63 Million investment
Geneva-based Addex Therapeutics and funds affiliated with Perceptive Advisors, an investment management firm focused on the life sciences sector, today announced the launch of Neurosterix to accelerate development of allosteric modulator therapeutics for neurological disorders. With initial funding of $63 million from Perceptive Xontogeny Venture Fund II, Neurosterix will acquire a portfolio of…
Read MoreVolumina Medical secures USD 21 Million Funding
Volumina Medical, a clinical stage MedTech company developing novel biomaterials for dermatology and plastic surgery, announces the successful closing of their Series A round by existing and new investors. It will enable Volumina Medical to confidently advance its clinical program with its lead product AdipearlTM, and ultimately achieve market approval in key international markets. …
Read More